NovaBay Pharma (NBY) Misses Q3 EPS by 18c
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $0.08 +14.29%
Revenue Growth %: -14.6%
Financial Fact:
Basic and diluted (in Dollars per share): -0.34
Today's EPS Names:
SEIC, OSBC, USAP, More
Revenue Growth %: -14.6%
Financial Fact:
Basic and diluted (in Dollars per share): -0.34
Today's EPS Names:
SEIC, OSBC, USAP, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q3 EPS of ($0.34), $0.18 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $3.4 million versus the consensus estimate of $3.02 million.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Visa (V) stock rises as Q2 earnings, revenue come ahead of estimates
- Eni S.p.A. (E) Reports Q1 EPS of EUR0.48; offers outlook
- Weatherford International plc (WFRD) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
